Clinical Trial

The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Study acronym: B-SOCIAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this qualitative study is to explore the impact of antiviral treatment, or none, for chronic hepatitis B virus on the non-clinical (social) harms experienced by migrant populations living in the UK. Two groups of participants living with hepatitis B virus will be interviewed, those taking the daily treatment, and those not prescribed any treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-26.
Trial Details
NCT Number NCT07053449
Lead Sponsor Nottingham University Hospitals NHS Trust
Conditions Hepatitis B Virus (HBV)
Enrollment 30 participants
Start Date 2025-08
Primary Completion 2025-12 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-07-16